(Q77115962)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10169670%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

title

An economic analysis of the Survival and Ventricular Enlargement (SAVE) Study. Application to the United Kingdom (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10169670%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

1 reference

S Hummel

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10169670%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

J Piercy

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10169670%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

R Wright

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10169670%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

A Davie

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10169670%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

A Bagust

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10169670%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

J McMurray

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10169670%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

publication date

1 August 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10169670%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10169670%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10169670%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

issue

2 Pt 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10169670%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

page(s)

182-192

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10169670%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.2165/00019053-199712020-00008

3 December 2019

exact match

0 references

cites work

Cost-effectiveness: a new criterion for selecting therapy.

1 reference

12 December 2020

Cost effective analyses in the treatment of high blood pressure

1 reference

12 December 2020

Discounting and health benefits: another perspective

1 reference

12 December 2020

GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto Miocardico

1 reference

12 December 2020

Costs and effectiveness of angiotensin converting enzyme inhibition in patients with congestive heart failure

1 reference

12 December 2020

Assessing the economic value of antihypertensive medicines

1 reference

12 December 2020

Effects of ACE inhibitors on heart failure in The Netherlands: a pharmacoeconomic model

1 reference

12 December 2020

Some guidelines on the use of cost effectiveness league tables

1 reference

12 December 2020

Discounting of health benefits in the pharmacoeconomic analysis of drug therapies: an issue for debate?

1 reference

12 December 2020

Effects of captopril on ischemic events after myocardial infarction. Results of the Survival and Ventricular Enlargement trial. SAVE Investigators

1 reference

12 December 2020

Cost-effectiveness of thrombolysis--a randomized study of intravenous rt-PA in suspected myocardial infarction

1 reference

12 December 2020

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

12 December 2020

ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collabor

1 reference

12 December 2020

Economic consequences of postinfarction prophylaxis with beta blockers: cost effectiveness of metoprolol

1 reference

12 December 2020

Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators

1 reference

12 December 2020

Influence on prognosis and morbidity of left ventricular ejection fraction with and without signs of left ventricular failure after acute myocardial infarction

1 reference

12 December 2020

Cost-utility analysis

1 reference

12 December 2020

Discounting and health benefits

1 reference

12 December 2020

Implications for present and future applications of the implantable cardioverter-defibrillator resulting from the use of a simple model of cost efficacy

1 reference

12 December 2020

Costs and effectiveness of routine therapy with long-term beta-adrenergic antagonists after acute myocardial infarction

1 reference

12 December 2020

Health service costs of coronary angioplasty and coronary artery bypass surgery: the Randomised Intervention Treatment of Angina (RITA) trial

1 reference

12 December 2020

Cost effectiveness of the implantable cardioverter defibrillator: a preliminary analysis

1 reference

12 December 2020

Promoting cost effective prescribing

1 reference

12 December 2020

Time preference, duration and health state valuations

1 reference

12 December 2020